Medicine Merck Obtains Global License for Hansoh’s HS-10535 By admin December 19, 2024 0 Comment on Merck Obtains Global License for Hansoh’s HS-10535 The molecule is an investigational pre-clinical oral GLP-1 receptor agonist.
